TOLEDO, Ohio, Nov. 17, 2020 /PRNewswire/ -- INFINITY ANGIOPLASTY BALLOON CO., announced today that its innovative PRECISION ANGIOPLASTY™ balloon platform – INFINITY ANGIOPLASTY BALLOON CATHETER™ has ...

First-line treatment with catheter ablation is superior to drug therapy for reducing atrial fibrillation, according to five year results from the MANTRA-PAF trial presented for the first time at ESC ...

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted a new indication to a cryoballoon ablation catheter that allows it to be used as a first-line ...

ALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, ...

TruLeaf from the AllMeD Solutions group, successfully completed the first phase of a first-in-human clinical trial of a revolutionary system for tricuspid and mitral heart valve implantation via ...

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...

A team of engineers and physicians has developed a steerable catheter that for the first time will give neurosurgeons the ability to steer the device in any direction they want while navigating the ...

This is the first dedicated diagnostic catheter made available for Stereotaxis’ robotic technology, complementing robotic ablation catheter innovations. “Stereotaxis is rapidly evolving towards ...